In a large-scale trial, modRNA was significantly better at preventing confirmed flu cases than a typical seasonal flu shot.

Vaccine mismatches may raise severity risks this flu season. Low vaccination uptake increases overall flu transmission ...

A Fredericton-based pharmacist says people are still showing up to get vaccinated for influenza, despite recent news that ...

Health experts warn this flu season could be unusually severe, with early spread and concerning H3N2 strain activity across ...

Flu cases are rising in eastern Pennsylvania and both St. Luke’s and LVHN are seeing some patients present to the hospital ...

Cell-based influenza vaccines were superior to egg-based vaccines across patient populations during a recent influenza season ...

Massachusetts makes flu vaccines more accessible with new standing order, allowing qualified health personnel to administer ...

A new flu variant, called subclade K, is spreading overseas and may set the stage for another tough winter in the United ...

Officials have deemed terms like “immunizations” and “vaccines” risky “buzzwords” that require approval to be used in social ...

Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. | Pfizer has ...

Peng Zhibin, a researcher at the Chinese Center for Disease Control and Prevention, said the current winter flu season is ...